Insulin glargine (also known as Lantus) is a diabetic insulin medicine of long-lasting origin that is used to control high blood sugar. The medication is used during the evening or night hours by people having Type 1 diabetes, latent autoimmune diabetes of adults or, rarely, in Type 2 diabetes. The medication is used with other insulins, including mealtime insulin.
Oral diabetes medication, insulins and insulin analogs, and other drugs used in diabetes (A10) |
|---|
|
|---|
| fast-acting | |
|---|
| short-acting | |
|---|
| long-acting |
- Insulin detemir#
- Insulin glargine# (+lixisenatide)
- NPH insulin
- Lente insulin‡
- Ultralente insulin‡
|
|---|
| ultra-long-acting |
- Insulin degludec# (+insulin aspart, +liraglutide)
|
|---|
| inhalable | |
|---|
|
|
Non-insulins |
|---|
| Insulin sensitizers | | Biguanides | |
|---|
| TZDs/"glitazones" (PPAR) |
- Ciglitazone§
- Darglitazone§
- Englitazone§
- Lobeglitazone
- Netoglitazone§
- Pioglitazone
- Rivoglitazone†
- Rosiglitazone
- Troglitazone‡
|
|---|
| Dual PPAR agonists |
- Aleglitazar†
- Muraglitazar§
- Saroglitazar
- Tesaglitazar§
|
|---|
|
|---|
| Secretagogues | | K+ATP | | Sulfonylureas |
- 1st generation: Acetohexamide
- Carbutamide
- Chlorpropamide
- Glycyclamide
- Metahexamide
- Tolazamide
- Tolbutamide
- 2nd generation: Glibenclamide (glyburide)
- Glibornuride
- Glicaramide
- Gliclazide#
- Glimepiride
- Glipizide
- Gliquidone
- Glisoxepide
- Glyclopyramide
|
|---|
| Meglitinides/"glinides" |
- Mitiglinide
- Nateglinide
- Repaglinide
|
|---|
|
|---|
| GLP-1/GIP receptor agonists |
- Albiglutide‡
- Danuglipron
- Dulaglutide
- Exenatide
- Liraglutide
- Lixisenatide
- Lotiglipron
- Orforglipron§
- Retatrutide§
- Semaglutide
- Taspoglutide†
- Tirzepatide
|
|---|
| DPP-4 inhibitors/"gliptins" |
- Alogliptin
- Anagliptin
- Evogliptin
- Garvagliptin
- Gemigliptin
- Gosogliptin
- Linagliptin
- Melogliptin
- Omarigliptin
- Saxagliptin
- Sitagliptin
- Teneligliptin
- Trelagliptin
- Vildagliptin
|
|---|
| FFAR1 agonists | |
|---|
|
|---|
| Other | | Aldose reductase inhibitors |
- Epalrestat
- Fidarestat§
- Ranirestat†
- Tolrestat‡
- Zenarestat§
|
|---|
| Alpha-glucosidase inhibitors |
- Acarbose
- Miglitol
- Voglibose
|
|---|
| Amylin analog | |
|---|
| SGLT2 inhibitors/"gliflozins" |
- Canagliflozin
- Dapagliflozin
- Empagliflozin#
- Ertugliflozin
- Ipragliflozin
- Luseogliflozin
- Remogliflozin§
- Sergliflozin§
- Tofogliflozin†
|
|---|
| Other |
- Benfluorex‡
- Bromocriptine
- Imeglimin
|
|---|
|
|---|
| Combinations |
- Alogliptin/metformin
- Canagliflozin/metformin
- Dapagliflozin/metformin
- Dapagliflozin/saxagliptin
- Dapagliflozin/saxagliptin/metformin
- Empagliflozin/linagliptin
- Empagliflozin/metformin
- Gemigliptin/rosuvastatin
- Glibenclamide (glyburide)/metformin
- Glimepiride/rosiglitazone
- Linagliptin/metformin
- Metformin/acarbose
- Metformin/ertugliflozin
- Metformin/evogliptin
- Metformin/gemigliptin
- Metformin/repaglinide
- Metformin/sulfonylureas
- Phenformin/sulfonylureas
- Pioglitazone/alogliptin
- Pioglitazone/glimepiride
- Pioglitazone/metformin
- Pioglitazone/sitagliptin
- Rosiglitazone/metformin
- Saxagliptin/metformin
- Sitagliptin/ertugliflozin
- Sitagliptin/metformin
- Sitagliptin/simvastatin
- Vildagliptin/metformin
|
|
|---|
|
|